| Literature DB >> 35481910 |
Abby Ivey1, Hillary Pratt1, Brian A Boone1,2.
Abstract
Gastric adenocarcinoma (GC) is a devastating disease and is the third leading cause of cancer deaths worldwide. This heterogeneous disease has several different classification systems that consider histological appearance and genomic alterations. Understanding the etiology of GC, including infection, hereditary conditions, and environmental factors, is of particular importance and is discussed in this review. To improve survival in GC, we also must improve our therapeutic strategies. Here, we discuss new targets that warrant further exploration.Entities:
Keywords: Her2; angiogenesis; gastric cancer; immunotherapy
Mesh:
Year: 2022 PMID: 35481910 PMCID: PMC9069999 DOI: 10.1002/jso.26874
Source DB: PubMed Journal: J Surg Oncol ISSN: 0022-4790 Impact factor: 2.885